Cancers MDPI shared a post on LinkedIn:
”Check out the Editor’s Choice Article ‘Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer‘ by Brittney Shulman Zimmerman and Francisco J. Esteva.
I believe that this article would be worth highlighting as it addresses one of the newest and most exciting areas of cancer therapeutics.”
